DOP39 Safety of combination biologic and anti-rejection...

Journal of Crohn's and Colitis 2019 / 01 Vol. 13; Iss. Supplement

DOP39 Safety of combination biologic and anti-rejection therapy post-liver transplantation in patients with inflammatory bowel disease: London Ontario experience

Al Draiweesh, S, Ma, C, Alkhattabi, M, Chande, N, Feagan, B G, Gregor, J C, Khanna, R, Marotta, P, Sandhu, A, Qumosani, K, Teriaky, A, Brahmania, M, Jairath, V
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
Journal of Crohn's and Colitis
DOI:
10.1093/ecco-jcc/jjy222.073
Date:
January, 2019
File:
PDF, 85 KB
english, 2019
Conversion to is in progress
Conversion to is failed